Skip to main content
. 2016 Feb 17;7(12):13976–13983. doi: 10.18632/oncotarget.7468

Figure 2. Association of prespecified IFN-inducible CXCR3 ligands (ICL) score with OS and RFS in non-metastatic ccRCC patients.

Figure 2

(A) Schematic diagram for the patients with different CXCL9, CXCL10 and CXCL11 expression. (B) Kaplan-Meier analysis of OS and RFS subgrouped by prespecified ICL score. (C) Schematic diagram for the patients with different CXCL9, CXCL10 and CXCL11 expression in TCGA database (z-score threshold is 0.8). (D) Kaplan-Meier analysis of OS and RFS dichotomized by alteration of CXCL9, CXCL10 and CXCL11.